Charles River Laboratories International (CRL) Liabilities from Discontinued Operations (2009 - 2018)
Charles River Laboratories International (CRL) recorded quarterly Liabilities from Discontinued Operations of 1671000.0 in Q1 2018, down 57.61% quarter-over-quarter from 3942000.0 in Q4 2017, and down 68.47% on a YoY basis from 5300000.0 in Q1 2017.
Charles River Laboratories International (CRL) Liabilities from Discontinued Operations (2009 - 2018) Analysis & Trends
Charles River Laboratories International's Liabilities from Discontinued Operations history runs 10 years deep, the most recent figure standing at 1671000.0 for Q1 2018.
- In Q1 2018, Liabilities from Discontinued Operations fell 68.47% year-over-year to 1671000.0; the TTM figure through Mar 2018 stood at 1671000.0 (down 68.47% YoY), while the FY2017 annual figure was 3942000.0, down 31.69% from the prior year.
- Liabilities from Discontinued Operations was 1671000.0 for Q1 2018 at Charles River Laboratories International, down from 3942000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 7890000.0 in Q4 2015 to a low of 1636000.0 in Q3 2017.
- Historically, Liabilities from Discontinued Operations has averaged 4149176.47 across 5 years, with a median of 2409000.0 in 2015.
- The sharpest annual moves came in 2015 and 2017: Liabilities from Discontinued Operations soared 246.03% in 2015, then slumped 76.94% in 2017.
- A 5-year view of Liabilities from Discontinued Operations shows it stood at 2299000.0 in 2014, then soared by 243.19% to 7890000.0 in 2015, then fell by 26.86% to 5771000.0 in 2016, then sank by 31.69% to 3942000.0 in 2017, then slumped by 57.61% to 1671000.0 in 2018.
- The last three Liabilities from Discontinued Operations figures came in at 1671000.0 (Q1 2018), 3942000.0 (Q4 2017), and 1650000.0 (Q3 2017), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Charles River Laboratories International | 9.42 Bn | 9.21 Bn | 744.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 1.67 Mn |
| Mar 31, 2018 | 1.67 Mn |
| Dec 30, 2017 | 3.94 Mn |
| Dec 30, 2017 | 3.94 Mn |
| Sep 30, 2017 | 1.65 Mn |
| Sep 30, 2017 | 1.65 Mn |
| Jul 1, 2017 | 1.64 Mn |
| Jul 1, 2017 | 1.64 Mn |
| Apr 1, 2017 | 5.30 Mn |
| Apr 1, 2017 | 5.30 Mn |
| Dec 31, 2016 | 5.77 Mn |
| Dec 31, 2016 | 5.77 Mn |
| Sep 24, 2016 | 1.76 Mn |
| Sep 24, 2016 | 1.76 Mn |
| Jun 25, 2016 | 7.09 Mn |
| Jun 25, 2016 | 7.09 Mn |
| Mar 26, 2016 | 7.42 Mn |
| Mar 26, 2016 | 7.42 Mn |
| Dec 26, 2015 | 7.89 Mn |
| Dec 26, 2015 | 7.89 Mn |